leuprorelin acetate · Medicine question

Which children is leuprorelin acetate (Prostap SR) licensed to treat for central precocious puberty?

Name: Which children is leuprorelin acetate (Prostap SR) licensed to treat for central precocious puberty?
Published: 2026-11-08T01:55:58.446Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Leuprorelin acetate (Prostap SR) is licensed to treat central precocious puberty in girls under 9 years of age and boys under 10 years of age.

Sources for this answer

Prostap SR DCSTakeda UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 25Document updated 24 June 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about leuprorelin acetate